NASDAQ:AMEH

Apollo Medical (AMEH) Stock Forecast, Price & News

$30.42

-0.19 (-0.62%)

(As of 09:30 AM ET)

Compare

Today's Range: $30.42
▼
$30.42
50-Day Range: $29.94
▼
$39.33
52-Week Range: $26.89
▼
$40.81

Volume: 1,092 shs
Average Volume: 173,998 shs
Market Capitalization: $1.75 billion

P/E Ratio: 27.91
Dividend Yield: N/A
Price Target: $52.00

Apollo Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 70.9% Upside
$52.00 Price Target
Short Interest: Bearish
7.89% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.69
Upright™ Environmental Score
News Sentiment: 0.79
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 21.62%
From $1.11 to $1.35 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Medical Sector

166th out of 965 stocks

Management Consulting Services Industry

8th out of 15 stocks

3.3

Analyst's Opinion

Consensus Rating
Apollo Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $52.00, Apollo Medical has a forecasted upside of 70.9% from its current price of $30.42.
Amount of Analyst Coverage
Apollo Medical has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
7.89% of the float of Apollo Medical has been sold short.
Short Interest Ratio / Days to Cover
Apollo Medical has a short interest ratio ("days to cover") of 15.7, which indicates bearish sentiment.
Change versus previous month
Short interest in Apollo Medical has recently decreased by 11.04%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Apollo Medical does not currently pay a dividend.
Dividend Growth
Apollo Medical does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Apollo Medical has received a 64.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Health care management software" and "Management consulting for medical care" products. See details.
Environmental Sustainability
The Environmental Impact score for Apollo Medical is -0.69.

2.7

News and Social Media Coverage

News Sentiment
Apollo Medical has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Apollo Medical this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for AMEH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Apollo Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Apollo Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.46% of the stock of Apollo Medical is held by insiders.
Percentage Held by Institutions
Only 35.88% of the stock of Apollo Medical is held by institutions.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Apollo Medical are expected to grow by 21.62% in the coming year, from $1.11 to $1.35 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Apollo Medical is 27.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.58.
Price to Earnings Ratio vs. Sector
The P/E ratio of Apollo Medical is 27.91, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 99.76.
Price to Earnings Growth Ratio
Apollo Medical has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Apollo Medical has a P/B Ratio of 3.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Apollo Medical (NASDAQ:AMEH) Stock

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

AMEH Price History

30 days | 90 days | 365 days | Advanced Chart

AMEH Stock News Headlines

October 2, 2023 | americanbankingnews.com

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Short Interest Down 11.0% in September

October 1, 2023 | msn.com

Apollo celebrates 30th anniversary of cancer centre

October 4, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.

September 28, 2023 | msn.com

Apollo purchases partially built hospital in Kolkata, India

September 27, 2023 | prnewswire.com

Apollo Medical Holdings, Inc. Releases Inaugural ESG At-a-Glance Report, Highlighting its Commitment to Advancing Health Equity in Local Communities

September 20, 2023 | msn.com

Is the new Apollo humanoid the end of jobs as we know it?

August 9, 2023 | finance.yahoo.com

/C O R R E C T I O N -- Apollo Medical Holdings, Inc./

August 8, 2023 | insidermonkey.com

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Q2 2023 Earnings Call Transcript

October 4, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

August 8, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. (AMEH) Meets Q2 Earnings Estimates

August 4, 2023 | benzinga.com

Apollo Medical Hlgs's Earnings Outlook

August 2, 2023 | seekingalpha.com

Apollo Medical Holdings: Rich Premium But Returning To Its Former Self

July 31, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. Announces Partnership with IntraCare to Advance Value-Based Care in Texas and Oklahoma

July 12, 2023 | markets.businessinsider.com

ApolloMed Buys Assets Of TIP, Expanding Care Partners Business Into Texas Geography

July 12, 2023 | msn.com

Apollo Medical to buy assets of Texas Independent Providers

July 12, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston

July 6, 2023 | msn.com

Apollo Medical Holdings (AMEH) Price Target Increased by 9.86% to 53.04

June 9, 2023 | finance.yahoo.com

Zacks Industry Outlook Highlights Medpace, HealthEquity and Apollo Medical

June 7, 2023 | finance.yahoo.com

Wall Street Analysts Believe Apollo Medical Holdings, Inc. (AMEH) Could Rally 59.78%: Here's is How to Trade

May 23, 2023 | msn.com

Unusual Call Option Trade in Apollo Medical Holdings (AMEH) Worth $93.25K

May 22, 2023 | finance.yahoo.com

Apollo Medical Holdings (NASDAQ:AMEH) Hasn't Managed To Accelerate Its Returns

May 11, 2023 | finance.yahoo.com

Is Hims & Hers Health (HIMS) Stock Outpacing Its Medical Peers This Year?

May 11, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. (AMEH) Upgraded to Strong Buy: Here's Why

May 9, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apollo Medical Holdings (AMEH), Arcellx Inc (ACLX) and ZimVie Inc (ZIMV)

May 1, 2023 | finance.yahoo.com

Apollo Medical Holdings, Inc. (AMEH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

April 19, 2023 | finance.yahoo.com

Strength Seen in Teladoc (TDOC): Can Its 5.7% Jump Turn into More Strength?

April 13, 2023 | msn.com

B of A Securities Initiates Coverage of Apollo Medical Holdings (AMEH) with Neutral Recommendation

See More Headlines

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Company Calendar

Last Earnings: 8/07/2023
Today: 10/03/2023
Next Earnings (Estimated): 11/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Management consulting services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AMEH
CUSIP: N/A
CIK: 1083446
Web: www.apollomed.net
Phone: (626) 282-0288
Fax: 818-839-5190
Employees: 1,362
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $52.00
High Stock Price Forecast: $60.00
Low Stock Price Forecast: $44.00
Forecasted Upside/Downside: +70.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.09
Trailing P/E Ratio: 27.91
Forward P/E Ratio: 27.41
P/E Growth: 2.43
Net Income: $45.17 million
Net Margins: 3.95%
Pretax Margin: 7.91%
Return on Equity: 11.00%
Return on Assets: 6.09%

Debt

Debt-to-Equity Ratio: 0.36
Current Ratio: 2.50
Quick Ratio: 2.50

Sales & Book Value

Annual Sales: $1.14 billion
Price / Sales: 1.53
Cash Flow: $1.24 per share
Price / Cash Flow: 24.57
Book Value: $9.60 per share
Price / Book: 3.17

Miscellaneous

Outstanding Shares: 57,560,000
Free Float: 52,692,000
Market Cap: $1.75 billion
Optionable: Not Optionable
Beta: 0.89

Social Links

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Dr. Kenneth T. Sim M.D. (Age 69)
Exec. Chairman
Comp: $1.49M

Dr. Thomas S. Lam M.D. (Age 74)
M.P.H., Pres, Co-CEO & Director
Comp: $1.49M

Mr. Brandon Sim (Age 29)
Co-Chief Exec. Officer
Comp: $1.73M

Mr. Chandan Basho (Age 41)
Chief Strategy Officer, CFO & Corp. Sec.
Comp: $581.42k

Dr. WaiChow Young M.D. (Age 76)
Chief Admin. Officer
Comp: $573.67k

Mr. John Vong (Age 50)
Chief Accounting Officer

Dr. Jeremy R. Jackson M.D.
Chief Quality Officer

Mr. Neil Ahuja
Pres of Provider Solutions

Yubin Park
Chief Analytics Officer

Dr. Carlos Palacios M.D.
Chief Medical Officer for Texas

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AMEH Stock - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.
What is Apollo Medical's stock price forecast for 2023?: 2 equities research analysts have issued 1-year price objectives for Apollo Medical's stock. Their AMEH share price forecasts range from $44.00 to $60.00. On average, they anticipate the company's share price to reach $52.00 in the next twelve months. This suggests a possible upside of 70.9% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.
How have AMEH shares performed in 2023?: Apollo Medical's stock was trading at $29.59 on January 1st, 2023. Since then, AMEH shares have increased by 2.8% and is now trading at $30.42.
View the best growth stocks for 2023 here.
Are investors shorting Apollo Medical?: Apollo Medical saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 2,740,000 shares, a decline of 11.0% from the August 31st total of 3,080,000 shares. Based on an average trading volume of 174,000 shares, the days-to-cover ratio is presently 15.7 days. Currently, 7.9% of the company's shares are short sold.
View Apollo Medical's Short Interest.
When is Apollo Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AMEH earnings forecast.
How were Apollo Medical's earnings last quarter?: Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its quarterly earnings results on Monday, August, 7th. The company reported $0.28 earnings per share for the quarter, meeting analysts' consensus estimates of $0.28. The company earned $348.21 million during the quarter, compared to the consensus estimate of $341.10 million. Apollo Medical had a trailing twelve-month return on equity of 11.00% and a net margin of 3.95%.
What ETFs hold Apollo Medical's stock?: ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS) and Syntax Stratified SmallCap ETF (SSLY).iShares U.S. Healthcare Providers ETF (IHF).
What guidance has Apollo Medical issued on next quarter's earnings?: Apollo Medical issued an update on its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of $0.95-$1.20 for the period, compared to the consensus estimate of $1.16. The company issued revenue guidance of $1.30 billion-$1.50 billion, compared to the consensus revenue estimate of $1.38 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?: 15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.
What other stocks do shareholders of Apollo Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).
What is Apollo Medical's stock symbol?: Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."
How do I buy shares of Apollo Medical?: Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Apollo Medical's stock price today?: One share of AMEH stock can currently be purchased for approximately $30.42.
How much money does Apollo Medical make?: Apollo Medical (NASDAQ:AMEH) has a market capitalization of $1.75 billion and generates $1.14 billion in revenue each year. The company earns $45.17 million in net income (profit) each year or $1.09 on an earnings per share basis.
How many employees does Apollo Medical have?: The company employs 1,362 workers across the globe.
Does Apollo Medical have any subsidiaries?: The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..
Read More
How can I contact Apollo Medical?: Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 282-0288, via email at investors@apollomed.net, or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 10/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial